Lilly’s Antibody Clinical Trial in Nursing Homes Prevents COVID-19, Reduces Resident Risk Up to 80%

A Phase 3 clinical trial of an antibody drug that enrolled residents and staff at skilled nursing and assisted living facilities found that the treatment significantly reduced the risk of contracting symptomatic COVID-19. The antibody drug, bamlanivimab (LY-CoV555), was developed by pharmaceutical giant Eli Lilly and Company (NYSE: LLY) for clinical use with the Vancouver-based […]

How Lilly’s COVID-19 Nursing Home Trial Could Change the Future of Research in Long-Term Care

In normal times, setting up a clinical trial can take nine months or more, with the actual work going on for potentially years afterwards. But during COVID-19, researchers don’t have the benefit of time — especially when working to find therapeutic options for vulnerable seniors in nursing homes. *A phase-three clinical trial for a new […]

Why Even a COVID-19 Vaccine May Not Be a Silver Bullet for Nursing Home Residents, Staff

The prospect of a COVID-19 vaccine sits at the center for the public’s hope of any return to pre-pandemic normalcy: With no effective treatments and outbreaks rising alongside relaxed lockdown rules, it’s difficult to imagine any real change without a proven vaccine. But in a twist of dark irony, the population most susceptible to COVID-19 […]

Eli Lilly Launches COVID-19 Clinical Trial in Nursing Homes with Symphony as Partner

Pharmaceutical giant Eli Lilly and Company (NYSE: LLY) will soon begin a phase-three clinical trial of a potential coronavirus treatment in the long-term care setting, with nursing home operator Symphony Care Network as a partner. Up to 2,400 residents and staff of nursing homes and assisted living properties will participate in the on-site study, the […]

Warren Presses HHS Pick Over Anti-Psychotic Drugs in Nursing Homes

President Trump’s pick to lead the Department of Health and Human Services faced pointed questions Wednesday about his former employer’s history with marketing anti-psychotic drugs to nursing home operators. Alex Azar, most recently a top executive at pharmaceutical giant Eli Lilly and Company (NYSE: LLY), pushed back against criticism of his former company’s history with […]